Investors

Impacting society, creating change

Researchers at Ohio State disclose more than 300 new inventions each year across a spectrum of sectors and applications. Startups offer a compelling, flexible path to advance innovations toward commercial adoption and success.

Ohio State’s startup portfolio is growing and creatively disrupting industries such as healthcare, information technology, materials,  transportation, agribusiness and more producing profound change in the way we live.

Ohio State Startup Success

Startups evolving from Ohio State technology are showing promise through success.

  • Since FY2017, 75 startup companies have been created from Ohio State technology.
  • Exits: startups from the Ohio State portfolio have been acquired by global companies, including AveXis and Celenex.
  • Through the Keenan Center for Entrepreneurship, the university provides robust funding, services and programs to support Ohio State innovation. 
Learn more about the companies in the Ohio State startup portfolio.

Ohio State Startups Catalog

The Ohio State startup portfolio is growing and making waves in the way the world lives. Ohio State’s startup portfolio is creating change in many industries, including healthcare, information technology, materials, transportation, agribusiness and more. Search our online database of current startups in Ohio State's portfolio.  

Contact Us

Connect with our new ventures team to learn more about investing in Ohio State startups.

Senior Director, Keenan Center for Entrepreneurship

Cheryl Turnbull


Manager, Keenan Center for Entrepreneurship

Kate Schulhaus, PhD


Grants & Contracts Specialist

Corine St. Gelais


Senior Analyst

Lauryn Betterton


Data Specialist

Malin Bryson


Director, Entrepreneurial Programs

Scott Griffin


Director of Entrepreneurial Education

Caroline Crisafulli

Executive Assistant to Cheryl Turnbull

Katie Musson

Director, Venture Development

Joe Chinnici

Program Coordinator

Ashley Lippincott

News & Events

  • Learn more about Ohio State's risk management tool on 6/2

    May 20, 2022

  • Drug developed by Ohio State Consortium shows promise in treating COVID-19 patients at high-risk for ARDS i...

    April 21, 2022

    The drug was partially developed by James Dalton during his time at Ohio State and the intellectual property exclusively licensed on a global basis by Veru is own...

View All